<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="The Coronavirus-associated disease, that was first identified in 2019 in" exact="China" post="(CoViD-19), is a pandemic caused by a bat-derived beta-coronavirus,"/>
 <result pre="homology with SARS and MERS-CoV, responsible for past outbreaks in" exact="China" post="and in Middle East. SARS-CoV2 spread from China where"/>
 <result pre="outbreaks in China and in Middle East. SARS-CoV2 spread from" exact="China" post="where the first infections were described in December 2019"/>
 <result pre="It was first reported in late December 2019 in Wuhan," exact="China" post="and the disease was officially named CoViD-19 by the"/>
 <result pre="many countries worldwide with a significant rate of infection in" exact="Italy" post="that currently accounts for more than 110,000 infected cases"/>
 <result pre="the Middle East Respiratory Syndrome (MERS)-CoV responsible for infections in" exact="Saudi Arabia" post="in 2012, respectively. Both these viruses had intermediate hosts"/>
 <result pre="hydroxychloroquine in CoViD-19 patients. Hydroxychloroquine is thus being used in" exact="Italy" post="for the treatment of CoViD-19 patients despite the absence"/>
 <result pre="uncomplicated SARS or MERS infection [10,11]. Recent preliminary data from" exact="China" post="reported high plasma levels of cytokines including IL-6, related"/>
 <result pre="single dose of tocilizumab was used in 21 patients in" exact="China" post="suffering from severe respiratory syndrome during CoViD-19 infection, at"/>
 <result pre="current measures. From the epidemiology of SARS-CoV and SARS-CoV2 in" exact="China" post="we have learned how fundamental are measures such as"/>
 <result pre="of a CoViD-19 infection. Furthermore, an international registry supported by" exact="America" post="College of Rheumatology, European League Against Rheumatism and other"/>
</results>
